Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Di Cosimo

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 5, 2020
VMAT partial-breast irradiation: acute toxicity of hypofractionated schedules of 30 Gy in five daily fractionsE La Rocca, L Lozza, E D' Ippolito, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2006
A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive diseaseP Papaldo, A Fabi, G Ferretti, et al.
Journal of Cancer Research and Clinical Oncology|May 15, 2020
Older age and comorbidity in breast cancer: is RT alone the new therapeutic frontier?E La Rocca, E Meneghini, L Lozza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2012
Management of the axilla in early breast cancer patients in the genomic eraM Oliveira, J Cortés, M Bellet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Incidence of chemotherapy-induced amenorrhea depending on the timing of treatment by menstrual cycle phase in women with early breast cancerS Di Cosimo, A Alimonti, G Ferretti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 11, 2011
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factorsC Serrano, J Cortés, L De Mattos-Arruda, et al.
Breast (Edinburgh, Scotland)|August 1, 2016
Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapyM C De Santis, F Bonfantini, F Di Salvo, et al.
British Journal of Cancer|June 1, 2006
Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trialsG Ferretti, E Bria, D Giannarelli, et al.
ESMO Open|March 9, 2024
Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysisG Nader-Marta, M Monteforte, E Agostinetto, et al.
Journal of Cancer Research and Clinical Oncology|April 9, 2022
Early stage breast cancer follow-up in real-world clinical practice: the added value of cell free circulating tumor DNAE La Rocca, M C De Santis, M Silvestri, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 5, 2020
VMAT partial-breast irradiation: acute toxicity of hypofractionated schedules of 30 Gy in five daily fractionsE La Rocca, L Lozza, E D' Ippolito, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 18, 2006
A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive diseaseP Papaldo, A Fabi, G Ferretti, et al.
Journal of Cancer Research and Clinical Oncology|May 15, 2020
Older age and comorbidity in breast cancer: is RT alone the new therapeutic frontier?E La Rocca, E Meneghini, L Lozza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2012
Management of the axilla in early breast cancer patients in the genomic eraM Oliveira, J Cortés, M Bellet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Incidence of chemotherapy-induced amenorrhea depending on the timing of treatment by menstrual cycle phase in women with early breast cancerS Di Cosimo, A Alimonti, G Ferretti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 11, 2011
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factorsC Serrano, J Cortés, L De Mattos-Arruda, et al.
Breast (Edinburgh, Scotland)|August 1, 2016
Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapyM C De Santis, F Bonfantini, F Di Salvo, et al.
British Journal of Cancer|June 1, 2006
Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trialsG Ferretti, E Bria, D Giannarelli, et al.
ESMO Open|March 9, 2024
Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysisG Nader-Marta, M Monteforte, E Agostinetto, et al.
Journal of Cancer Research and Clinical Oncology|April 9, 2022
Early stage breast cancer follow-up in real-world clinical practice: the added value of cell free circulating tumor DNAE La Rocca, M C De Santis, M Silvestri, et al.
Pageof 4